WO2008133332A1 - 基質濃度測定方法および基質濃度測定装置 - Google Patents

基質濃度測定方法および基質濃度測定装置 Download PDF

Info

Publication number
WO2008133332A1
WO2008133332A1 PCT/JP2008/058152 JP2008058152W WO2008133332A1 WO 2008133332 A1 WO2008133332 A1 WO 2008133332A1 JP 2008058152 W JP2008058152 W JP 2008058152W WO 2008133332 A1 WO2008133332 A1 WO 2008133332A1
Authority
WO
WIPO (PCT)
Prior art keywords
value
hemoglobin
concentration
substrate
concentration measurement
Prior art date
Application number
PCT/JP2008/058152
Other languages
English (en)
French (fr)
Inventor
Tatsuo Kamata
Takeshi Takagi
Yuki Ito
Original Assignee
Arkray, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Arkray, Inc. filed Critical Arkray, Inc.
Priority to EP08740891.0A priority Critical patent/EP2151682B1/en
Priority to US12/451,085 priority patent/US20100299072A1/en
Priority to JP2009511920A priority patent/JP4901956B2/ja
Publication of WO2008133332A1 publication Critical patent/WO2008133332A1/ja

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N27/00Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
    • G01N27/26Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
    • G01N27/28Electrolytic cell components
    • G01N27/30Electrodes, e.g. test electrodes; Half-cells
    • G01N27/327Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
    • G01N27/3271Amperometric enzyme electrodes for analytes in body fluids, e.g. glucose in blood
    • G01N27/3274Corrective measures, e.g. error detection, compensation for temperature or hematocrit, calibration
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366Apparatus specially adapted for solid-phase testing
    • G01N33/54373Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
    • G01N33/5438Electrodes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/72Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood pigments, e.g. haemoglobin, bilirubin or other porphyrins; involving occult blood
    • G01N33/721Haemoglobin
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/96Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood or serum control standard
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/04Preparation or injection of sample to be analysed
    • G01N30/06Preparation
    • G01N30/14Preparation by elimination of some components
    • G01N2030/146Preparation by elimination of some components using membranes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/84Preparation of the fraction to be distributed
    • G01N2030/8411Intermediate storage of effluent, including condensation on surface
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/88Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86
    • G01N2030/8809Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample
    • G01N2030/8813Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials
    • G01N2030/8822Integrated analysis systems specially adapted therefor, not covered by a single one of the groups G01N30/04 - G01N30/86 analysis specially adapted for the sample biological materials involving blood
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N30/00Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
    • G01N30/02Column chromatography
    • G01N30/86Signal analysis
    • G01N30/8603Signal analysis with integration or differentiation
    • G01N30/8606Integration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Electrochemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

 本発明は、ヘモグロビンを含む血液試料中の基質の濃度を測定する方法に関する。この方法では、血液試料中に含まれるヘモグロビン濃度を考慮して、基質濃度を演算する。基質濃度の演算にあたっては、たとえば下記数式1および2に基づいてヘモグロビン濃度に関する補正を行う。   【数1】 補正値=100×Re/V(%) V(%):対血漿値(血漿を測定したときの測定値に対するへモグロビンにより影響を受けた測定値の割合) Re:へモグロビンにより影響を受けた基質濃度に相関する測定値  【数2】 対血漿値V(%)=(Vmax×Re)/(Km+Re)+B Vmax:へモグロビンにより影響を受けた測定値が大きくなっても対血漿(V)が変化しない値から切片(B)を差し引いた値 Km:対血漿値V(%)がVmax/2となるときのRe B:Reが0のときの対血漿値V(%)の値(定数)    
PCT/JP2008/058152 2007-04-25 2008-04-25 基質濃度測定方法および基質濃度測定装置 WO2008133332A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP08740891.0A EP2151682B1 (en) 2007-04-25 2008-04-25 Substrate concentration measurement method and substrate concentration measurement apparatus
US12/451,085 US20100299072A1 (en) 2007-04-25 2008-04-25 Substrate concentration measurement method and substrate concentration measurement apparatus
JP2009511920A JP4901956B2 (ja) 2007-04-25 2008-04-25 基質濃度測定方法および基質濃度測定装置

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2007-116099 2007-04-25
JP2007116099 2007-04-25

Publications (1)

Publication Number Publication Date
WO2008133332A1 true WO2008133332A1 (ja) 2008-11-06

Family

ID=39925778

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2008/058152 WO2008133332A1 (ja) 2007-04-25 2008-04-25 基質濃度測定方法および基質濃度測定装置

Country Status (4)

Country Link
US (1) US20100299072A1 (ja)
EP (1) EP2151682B1 (ja)
JP (1) JP4901956B2 (ja)
WO (1) WO2008133332A1 (ja)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012027014A (ja) * 2010-06-23 2012-02-09 Arkray Inc 分析用試料調製用希釈液
WO2015111441A1 (ja) * 2014-01-27 2015-07-30 株式会社 日立ハイテクノロジーズ 自動分析装置
JP2016517514A (ja) * 2013-03-14 2016-06-16 インストゥルメンテーション ラボラトリー カンパニー 全血溶血センサ

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5888885B2 (ja) * 2010-06-23 2016-03-22 アークレイ株式会社 測定装置、測定方法、測定プログラム、および測定システム
US9939402B2 (en) * 2012-02-09 2018-04-10 Lg Electronics Inc. Blood sugar detecting method and cartridge using same
US9869654B2 (en) * 2013-11-29 2018-01-16 Broadmaster Biotech Corp. Method of measuring hematocrit (HCT), and measurement device using the method

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02159563A (ja) * 1988-12-12 1990-06-19 Hitachi Ltd 診断システム
JPH0933533A (ja) 1995-07-21 1997-02-07 Kdk Corp グルコース濃度の測定方法
JPH09318634A (ja) 1996-05-29 1997-12-12 Kdk Corp グルコース濃度の測定方法
JP2000346848A (ja) * 1999-06-04 2000-12-15 Tosoh Corp グルコースの測定方法及び測定装置
WO2005098424A1 (en) 2004-03-31 2005-10-20 Bayer Healthcare Llc Method and apparatus for implementing threshold based correction functions for biosensors
WO2005103669A1 (ja) * 2004-04-19 2005-11-03 Matsushita Electric Industrial Co., Ltd. 血液成分の測定方法、それに用いるバイオセンサおよび測定装置

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7597793B2 (en) * 2003-06-20 2009-10-06 Roche Operations Ltd. System and method for analyte measurement employing maximum dosing time delay

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH02159563A (ja) * 1988-12-12 1990-06-19 Hitachi Ltd 診断システム
JPH0933533A (ja) 1995-07-21 1997-02-07 Kdk Corp グルコース濃度の測定方法
JPH09318634A (ja) 1996-05-29 1997-12-12 Kdk Corp グルコース濃度の測定方法
JP2000346848A (ja) * 1999-06-04 2000-12-15 Tosoh Corp グルコースの測定方法及び測定装置
WO2005098424A1 (en) 2004-03-31 2005-10-20 Bayer Healthcare Llc Method and apparatus for implementing threshold based correction functions for biosensors
WO2005103669A1 (ja) * 2004-04-19 2005-11-03 Matsushita Electric Industrial Co., Ltd. 血液成分の測定方法、それに用いるバイオセンサおよび測定装置

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of EP2151682A4 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2012027014A (ja) * 2010-06-23 2012-02-09 Arkray Inc 分析用試料調製用希釈液
JP2016517514A (ja) * 2013-03-14 2016-06-16 インストゥルメンテーション ラボラトリー カンパニー 全血溶血センサ
WO2015111441A1 (ja) * 2014-01-27 2015-07-30 株式会社 日立ハイテクノロジーズ 自動分析装置
US10768189B2 (en) 2014-01-27 2020-09-08 Hitachi High-Tech Corporation Automatic analysis apparatus

Also Published As

Publication number Publication date
JP4901956B2 (ja) 2012-03-21
EP2151682B1 (en) 2014-09-17
EP2151682A1 (en) 2010-02-10
EP2151682A4 (en) 2013-05-15
JPWO2008133332A1 (ja) 2010-07-29
US20100299072A1 (en) 2010-11-25

Similar Documents

Publication Publication Date Title
WO2008133332A1 (ja) 基質濃度測定方法および基質濃度測定装置
Krüger et al. Seasonal variation in pathways of CH4 production and in CH4 oxidation in rice fields determined by stable carbon isotopes and specific inhibitors
WO2003016899A3 (en) Method and system for detection of hydrocarbon species in a gas
WO2006047182A8 (en) Method and apparatus for determining an analyte concentration in a sample having interferents
TW200745543A (en) System and methods for providing corrected analyte concentration measurements
WO2009063938A1 (ja) 酸素濃縮装置
MX340921B (es) Compensacion basada en la pendiente que incluye señales de salida secundarias.
EP1742045A4 (en) METHOD FOR MEASURING BLOOD COMPONENTS AND BIOSENSOR AND MEASURING INSTRUMENT FOR USE THEREWITH
WO2009108239A3 (en) Slope-based compensation
WO2007026335A3 (en) Methods for measuring moisture content of skin
WO2007120780A3 (en) Apparatus and method for measuring nitric oxide in exhaled breath
WO2006109279A3 (en) Analyte determination method and analyte meter
WO2007120381A3 (en) Analyte sensor
BR112014016232A2 (pt) medições precisas de analito para tira de teste eletroquímico com base em múltiplas medições discretas definidas pela(s) característica(s) física(s) detectada(s) da amostra contendo o analito
WO2003040728A3 (en) Method and apparatus for the determination of glucose
WO2006066274A3 (en) Breath-based sensors for non-invasive molecular detection
WO2008060694A3 (en) System and/or method for determining sufficiency of pseudorange measurements
NO20090088L (no) Stoyreduksjon i malinger av elektriske felter
EP2083263A3 (en) NOx sensor and production method thereof
WO2009031506A1 (ja) 低密度リポタンパク質(ldl)コレステロール測定方法およびldlコレステロール測定用試験片
CN103196892B (zh) 一种测定土壤中金属元素汞的方法
ATE445844T1 (de) Testverfahren mit einer sulfonsäure- und einer nitroverbindung
MX340107B (es) Metodo de medicion inmunologica para precurso de peptido que libera gastrina.
NO20071564L (no) Fremgangsmate for a bestemme konsentrasjonen av analytter i prover ved direkte formidling av enzymer
WO2005108649A3 (en) One-point recalibration method for reducing error in concentration measurements for an electrolytic solution

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08740891

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2009511920

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008740891

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12451085

Country of ref document: US